At a glance
ClinicalIndex Comparison RecordN/ACompleted· 35 enrolled
Drug / intervention
Cyclosporine Ophthalmic Emulsion 0.05%drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%
In Brief
An observational study evaluating Cyclosporine Ophthalmic Emulsion 0.05% for Dry Eye Disease. Completed, enrolled 35 participants across 1 site.
Detailed Summary
The objective of this retrospective chart review is to evaluate the patient characteristics, treatment variations and efficacy of a second trial of Cyclosporine Ophthalmic Emulsion 0.05% therapy in chronic dry eye patients who were initially treated with Cyclosporine Ophthalmic Emulsion 0.05% but discontinued use after less than 12 weeks of treatment.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2009
First PostedJan 2009
Primary CompletionJun 2009
Study CompletionOct 2009
TodayJul 2026
First PostedJan 22, 2009
Enrollment StartJan 1, 2009
Primary CompletionJun 1, 2009
Study CompletionOct 1, 2009
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 17.4 years ago
Interventions
Cyclosporine Ophthalmic Emulsion 0.05%drug
One drop two times a day approximately 12 hours apart